Bangladesh, a laggard in the production of raw materials for the $3 billion pharmaceuticals industry, has made a four-fold jump in the manufacturing of active pharmaceutical ingredient (API) in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results